1

BCIS NEWS

0 Comments

9 October 2017

Reopro / Abciximab national stocks running low

Previous | Next

Summary

See attached document for full details

 

In summary

• There is a temporary interruption of supply for ReoPro® that is likely to result in shortages to patients for the time period between October 2017 and March 2018.

• We estimate that hospital pharmacies will be out of stock by October 2017 or earlier.

• Please consider alternative medications such as other glycoprotein IIb/IIIa antagonists or Bivalirudin instead of ReoPro.

Summary

See attached document for full details

 

In summary

• There is a temporary interruption of supply for ReoPro® that is likely to result in shortages to patients for the time period between October 2017 and March 2018.

• We estimate that hospital pharmacies will be out of stock by October 2017 or earlier.

• Please consider alternative medications such as other glycoprotein IIb/IIIa antagonists or Bivalirudin instead of ReoPro.

Abciximab update

UK DHPC Reopro supplies

69.67 Kb

Read Next

BCIS AHP Working Group – new members required